Stock Events

Stock Events

LumiraDx Limited 

$0.01
17
+$0.01+900% Friday 19:25

Statistics

Day High
0.01
Day Low
0
52W High
0.31
52W Low
0
Volume
24,835
Avg. Volume
197,388
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

6NovExpected
Q1 2024
Q2 2024
Q3 2024
-0.13
-0.12
-0.12
-0.12
Expected EPS
-0.1167
Actual EPS
N/A

Financials

-175.97%Profit Margin
Unprofitable
2019
2020
2021
2022
254.48MRevenue
-447.79MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LMDXF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories competes with LumiraDx in the rapid diagnostics and point-of-care testing market, offering similar diagnostic solutions.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation, through its subsidiaries, provides a range of diagnostic solutions and products that compete with LumiraDx's offerings in the healthcare diagnostics sector.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific offers a wide range of diagnostics and healthcare solutions that compete with LumiraDx's diagnostic products and services.
QuidelOrtho
QDEL
Mkt Cap1.83B
Quidel Corporation specializes in diagnostic healthcare solutions similar to LumiraDx, particularly in the areas of rapid diagnostic testing.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories offers products and services in the field of clinical diagnostics and research, competing with LumiraDx in the diagnostics market.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. provides diagnostics products, medical imaging systems, and surgical products that compete with LumiraDx's diagnostic solutions.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company offers a variety of healthcare and diagnostic solutions, competing with LumiraDx in the medical technology and diagnostics field.
Resmed
RMD
Mkt Cap36.04B
ResMed Inc. competes with LumiraDx in the healthcare sector by offering products and solutions in sleep and respiratory medicine that overlap with LumiraDx's health diagnostics focus.
Bruker
BRKR
Mkt Cap5.91B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions that compete with LumiraDx in the field of diagnostics and healthcare research.

About

LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
Show more...
CEO
Mr. Ron Zwanziger
Employees
1500
Country
USA
ISIN
KYG5709L1095

Listings

0 Comments

Share your thoughts

FAQ

What is LumiraDx Limited stock price today?▼
The current price of LMDXF is $0.01 USD — it has increased by +900% in the past 24 hours. Watch LumiraDx Limited stock price performance more closely on the chart.
What is LumiraDx Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange LumiraDx Limited stocks are traded under the ticker LMDXF.
What is LumiraDx Limited revenue for the last year?▼
LumiraDx Limited revenue for the last year amounts to 254.48M USD.
What is LumiraDx Limited net income for the last year?▼
LMDXF net income for the last year is -447.79M USD.
How many employees does LumiraDx Limited have?▼
As of April 04, 2026, the company has 1,500 employees.
In which sector is LumiraDx Limited located?▼
LumiraDx Limited operates in the Healthcare sector.
When did LumiraDx Limited complete a stock split?▼
LumiraDx Limited has not had any recent stock splits.
Where is LumiraDx Limited headquartered?▼
LumiraDx Limited is headquartered in London, USA.